secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
CIK:        0001742927
Form:       8-K
Filed at:   2023-04-27T23:59:59+00:00
Accession:  0001437749-23-011379
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Reviva grants stock options to CEO, CFO, and VP; 1.303M shares total
--------------------------------------------------------------------

- CEO Dr. Bhat granted option for 443,000 shares; CFO Prabhu for 170,000 shares.
- VP Seema Bhat (CEO's spouse) granted option for 150,000 shares.
- Options vest 50% immediately, then 1.389% monthly; exercise price $6.74.
- Additional 540,000 options awarded to other employees under 2020 Plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1742927/000143774923011379/0001437749-23-011379-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1742927/000143774923011379/rvph20230426_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-011379

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer